Ψ-2C-T-4
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Ψ-2C-T-4, or psi-2C-T-4, also known as 4-isopropylthio-2,6-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and Ψ-PEA families.[1][4][2][3] It is a positional isomer of 2C-T-4 (4-isopropylthio-2,5-dimethoxyphenethylamine).[1][4][2][3]
- None
| Clinical data | |
|---|---|
| Other names | psi-2C-T-4; 4-Isopropylthio-2,6-dimethoxyphenethylamine; 2,6-Dimethoxy-4-isopropylthiophenethylamine |
| Routes of administration | Oral[1][2][3][4] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1][2][3][4] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C13H21NO2S |
| Molar mass | 255.38 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved), Ψ-2C-T-4 produced short-lasting threshold psychoactive effects at doses of 8 to 12 mg orally.[1][2][3] Higher doses were not assessed and its effective dose range has not been determined.[1][2][3] In a subsequent review, Shulgin stated that it was active at doses in the "10 to 20 mg range" but that more study was required to establish its dose range and effects.[4]
The chemical synthesis of Ψ-2C-T-4 has been described.[1]
The drug was first described in the scientific literature by Shulgin by 1991 and was further briefly described by him in 2003.[1][4][2] It is a controlled substance in Canada under phenethylamine blanket-ban language.[5]